BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15462261)

  • 21. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
    Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
    J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
    Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
    Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
    Goldstein W; Döring G
    Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
    Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunities for the use of aerosolized alpha 1-antitrypsin for the treatment of cystic fibrosis.
    Allen ED
    Chest; 1996 Dec; 110(6 Suppl):256S-260S. PubMed ID: 8989161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis.
    Döring G
    Pediatr Pulmonol; 1999 Nov; 28(5):363-75. PubMed ID: 10536068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil elastase: alpha-1-proteinase inhibitor complex in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis.
    Yamanouchi H; Fujita J; Hojo S; Yoshinouchi T; Kamei T; Yamadori I; Ohtsuki Y; Ueda N; Takahara J
    Eur Respir J; 1998 Jan; 11(1):120-5. PubMed ID: 9543280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil elastase-mediated lung disease.
    Sandhaus RA; Turino G
    COPD; 2013 Mar; 10 Suppl 1():60-3. PubMed ID: 23527919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
    Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
    Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
    Hansen G; Schuster A; Zubrod C; Wahn V
    Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elastase inhibitor for detection and treatment of inflammation and infection.
    Fricker J
    Mol Med Today; 1998 Jan; 4(1):5. PubMed ID: 9494959
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.
    Gaggar A; Chen J; Chmiel JF; Dorkin HL; Flume PA; Griffin R; Nichols D; Donaldson SH
    J Cyst Fibros; 2016 Mar; 15(2):227-33. PubMed ID: 26321218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil collagenase in sputum from patients with cystic fibrosis.
    Power C; O'Connor CM; MacFarlane D; O'Mahoney S; Gaffney K; Hayes J; FitzGerald MX
    Am J Respir Crit Care Med; 1994 Sep; 150(3):818-22. PubMed ID: 8087357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
    Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
    Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil elastase in the diagnosis of neonatal infection.
    Philip AG; Tito AM; Gefeller O; Speer CP
    Pediatr Infect Dis J; 1994 Apr; 13(4):323-6. PubMed ID: 8036053
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha1-proteinase inhibitor in the newborn - A comment.
    Kirpalani H
    Can Respir J; 1999; 6(2):136-7. PubMed ID: 10322095
    [No Abstract]   [Full Text] [Related]  

  • 37. Reducing neutrophil elastase-induced lung injury.
    Stiskal JA; O'Brien KK; Kelly EN; Dunn MS
    Can Respir J; 1999; 6(2):138-40. PubMed ID: 10322096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of a therapeutic agent for the treatment of chronic obstructive pulmonary disease in smokers.
    Turino GM; Davies P; Dunlap R; Krell RD; Maycock AL; Rennard S; Stockley RA
    Ann N Y Acad Sci; 1991 Dec; 624 Suppl():23-30. PubMed ID: 1686162
    [No Abstract]   [Full Text] [Related]  

  • 39. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
    McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
    J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte elastase-mediated proteolysis of alpha 1-antitrypsin in cystic fibrosis bronchopulmonary secretions.
    Cantin A; Bilodeau G; Bégin R
    Pediatr Pulmonol; 1989; 7(1):12-7. PubMed ID: 2788857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.